Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 4 Option exercise Chief Executive Officer acquired 20,000 shares (option exercise)
  2. 10-Q Report Quarterly Report
  3. 4 Open-market buy Director bought 1,000 shares at $82.52 ($82,520)
  4. PRE 14A Proxy Proxy Statement (Preliminary)
  5. 8-K Event Bylaws or fiscal year change
  6. 8-K Event Results of operations
  7. 8-K Event Results of operations · Regulation FD disclosure
  8. 8-K Event Material agreement · Regulation FD disclosure
  9. 3 Insider Initial Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure
  12. SC TO-T/A Deal Tender Offer Statement
  13. 8-K Event Material agreement
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. SC TO-T/A Deal Tender Offer Statement
  16. SC TO-T/A Deal Tender Offer Statement
  17. 8-K Event Material agreement
  18. SC TO-T Deal Tender Offer Statement
  19. SC 13D/A Stake Beneficial Ownership Report
  20. 4/A Open-market sale 10% owner sold 148,700 shares at $8.11 ($1,205,660)

Page 28 of 115 · 2,300 filings